Clinical trial
Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care
NCT02832297
Study timeline
Study start (actual)2016-06-01Date precision: month
Registry last updated2018-07-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Arthritis, Rheumatoidunresolved
Interventions
Vectra DAOTHER
Usual CareOTHER
Sponsors & collaborators
Crescendo Biosciencelead sponsor
Mapped research locations
LansingMichigan, United States2BaltimoreMaryland, United States1SeattleWashington, United States1Washington D.C.District of Columbia, United States1Ann ArborMichigan, United States1Las VegasNevada, United States1MemphisTennessee, United States1SpokaneWashington, United States1ClearwaterFlorida, United States1WilmingtonNorth Carolina, United States1HuntsvilleAlabama, United States1Chula VistaCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02832297 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.